Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical Orthopaedics and Related Research®
Published in: Clinical Orthopaedics and Related Research® 11/2011

01-11-2011 | Clinical Research

Similar Local Control between Phenol- and Ethanol-treated Giant Cell Tumors of Bone

Authors: Wei-Hsin Lin, MD, Tsung-Yu Lan, MD, Chih-Yu Chen, MD, Karl Wu, MD, Rong-Sen Yang, MD

Published in: Clinical Orthopaedics and Related Research® | Issue 11/2011

Login to get access

Abstract

Background

Giant cell tumors (GCTs) of bone often are treated with curettage, adjuvant therapy, and cementation. Phenol is a commonly used adjuvant associated with local control rates ranging from 9% to 25%. However, it is corrosive to the eyes, skin, and respiratory tract. Ethanol is readily available and does not cause chemical burns on contact, but it is unclear whether ethanol can achieve similar local control rates as phenol for treating GCTs.

Questions/purposes

We evaluated (1) the recurrence rate and recurrence-free Kaplan-Meier survival function, (2) Musculoskeletal Tumor Society (MSTS) functional score (1993 version), and (3) complications of two groups of patients with GCTs treated with extensive curettage, local adjuvant therapy with phenol or ethanol, and cement reconstruction, to determine if ethanol was a reasonable alternative to phenol.

Patients and Methods

We retrospectively reviewed all 26 patients with GCTs in the long bones of extremities treated with curettage, high-speed burring, phenolization, and cementation between May 1995 and November 2001, and 35 patients treated with the same protocol, except phenol was replaced with 95% ethanol, between November 2001 and November 2007. The recurrence rates, Kaplan-Meier recurrence-free survival curves, and MSTS functional scores of these two treatment groups were compared with Fisher’s exact test, Tarone-Ware test, and Mann-Whitney U test, respectively. The minimum followup was 36 months (mean, 58 months; range, 36–156 months).

Results

Local recurrence rates were similar in the two groups: 11% in the ethanol group and 12% in the phenol group. The survival curves (using local recurrence as an endpoint) of the two groups were similar. The mean MSTS functional score was 27.3 (91%) for the ethanol group and 26.9 (90%) for the phenol group.

Conclusions

Ethanol is a reasonable alternative to phenol when adjuvant therapy is considered in the treatment of GCTs of long bones.

Level of Evidence

Level III, therapeutic study. See Guidelines for Authors for a complete description of levels of evidence.
Literature
1.
Ahlback S. Osteoarthrosis of the knee: a radiographic investigation. Acta Radiol Diagn (Stockh). 1968:Suppl 277:7–72.
2.
Algawahmed H, Turcotte R, Farrokhyar F, Ghert M. High-speed burring with and without the use of surgical adjuvants in the intralesional management of giant cell tumor of bone: a systematic review and meta-analysis. Sarcoma. 2010;2010. pii: 586090. Epub 2010 Jul 27.
3.
Arbeitsgemeinschaft Knochentumoren, Becker WT, Dohle J, Bernd L, Braun A, Cserhati M, Enderle A, Hovy L, Matejovsky Z, Szendroi M, Trieb K, Tunn PU. Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy. J Bone Joint Surg Am. 2008;90:1060–1067.CrossRef
4.
Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G, Hardes J, Gosheger G. Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol. 2008;134:969–978.PubMedCrossRef
5.
Bas T, Aparisi F, Bas JL. Efficacy and safety of ethanol injections in 18 cases of vertebral hemangioma: a mean follow-up of 2 years. Spine(Phila Pa 1976). 2001;26:1577–1582.CrossRef
6.
Blackley HR, Wunder JS, Davis AM, White LM, Kandel R, Bell RS. Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg Am. 1999;81:811–820.PubMedCrossRef
7.
Campanacci M. Giant-cell tumor and chondrosarcomas: grading, treatment and results (studies of 209 and 131 cases). Recent Results Cancer Res. 1976;54:257–261.PubMed
8.
Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106–114.PubMed
9.
Cotten A, Demondion X, Boutry N, Cortet B, Chastanet P, Duquesnoy B, Leblond D. Therapeutic percutaneous injections in the treatment of malignant acetabular osteolyses. Radiographics. 1999;19:647–653.PubMed
10.
Crawford EA, Slotcavage RL, King JJ, Lackman RD, Ogilvie CM. Ethanol sclerotherapy reduces pain in symptomatic musculoskeletal hemangiomas. Clin Orthop Relat Res. 2009;467:2955–2961.PubMedCrossRef
11.
Davis AM, Wright JG, Williams JI, Bombardier C, Griffin A, Bell RS. Development of a measure of physical function for patients with bone and soft tissue sarcoma. Qual Life Res. 1996;5:508–516.PubMedCrossRef
12.
Deheshi BM, Jaffer SN, Griffin AM, Ferguson PC, Bell RS, Wunder JS. Joint salvage for pathologic fracture of giant cell tumor of the lower extremity. Clin Orthop Relat Res. 2007;459:96–104.PubMedCrossRef
13.
Durr HR, Maier M, Jansson V, Baur A, Refior HJ. Phenol as an adjuvant for local control in the treatment of giant cell tumour of the bone. Eur J Surg Oncol. 1999;25:610–618.PubMedCrossRef
14.
el-Mowafi H, Refaat H, Kotb S. Percutaneous destruction and alcoholisation for the management of osteoid osteoma. Acta Orthop Belg. 2003;69:447–451.PubMed
15.
Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ. A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res. 1993;286:241–246.PubMed
16.
Errani C, Ruggieri P, Asenzio MA, Toscano A, Colangeli S, Rimondi E, Rossi G, Longhi A, Mercuri M. Giant cell tumor of the extremity: a review of 349 cases from a single institution. Cancer Treat Rev. 2010;36:1–7.PubMedCrossRef
17.
Frassica FJ, Sim FH, Pritchard DJ, Chao EY. Subchondral replacement: a comparative analysis of reconstruction with methyl methacrylate or autogenous bone graft. Chir Organi Mov. 1990;75(1 suppl):189–190.PubMed
18.
Fujimoto T. The experimental and clinical studies of percutaneous ethanol injection therapy (PElT) under ultrasonography for small hepatocellular carcinoma. Acta Hepatol Jpn. 1988;29:52–59.CrossRef
19.
Gangi A, Kastler B, Klinkert A, Dietemann JL. Injection of alcohol into bone metastases under CT guidance. J Comput Assist Tomogr. 1994;18:932–935.PubMedCrossRef
20.
Ghert MA, Rizzo M, Harrelson JM, Scully SP. Giant-cell tumor of the appendicular skeleton. Clin Orthop Relat Res. 2002;400:201–210.PubMedCrossRef
21.
Gortzak Y, Kandel R, Deheshi B, Werier J, Turcotte RE, Ferguson PC, Wunder JS. The efficacy of chemical adjuvants on giant-cell tumour of bone: an in vitro study. J Bone Joint Surg Br. 2010;92:1475–1479.PubMedCrossRef
22.
Guglielmi R, Pacella CM, Bianchini A, Bizzarri G, Rinaldi R, Graziano FM, Petrucci L, Toscano V, Palma E, Poggi M, Papini E. Percutaneous ethanol injection treatment in benign thyroid lesions: role and efficacy. Thyroid. 2004;14:125–131.PubMedCrossRef
23.
Jones KB, DeYoung BR, Morcuende JA, Buckwalter JA. Ethanol as a local adjuvant for giant cell tumor of bone. Iowa Orthop J. 2006;26:69–76.PubMedCrossRef
24.
Kivioja AH, Blomqvist C, Hietaniemi K, Trovik C, Walloe A, Bauer HC, Jorgensen PH, Bergh P, Folleras G. Cement is recommended in intralesional surgery of giant cell tumors: a Scandinavian Sarcoma Group study of 294 patients followed for a median time of 5 years. Acta Orthop. 2008;79:86–93.PubMedCrossRef
25.
Klenke FM, Wenger DE, Inwards CY, Rose PS, Sim FH. Giant cell tumor of bone: risk factors for recurrence. Clin Orthop Relat Res. 2011;469:591–599.PubMedCrossRef
26.
Lackman RD, Hosalkar HS, Ogilvie CM, Torbert JT, Fox EJ. Intralesional curettage for grades II and III giant cell tumors of bone. Clin Orthop Relat Res. 2005;438:123–127.PubMedCrossRef
27.
Malawer MM, Bickels J, Meller I, Buch RG, Henshaw RM, Kollender Y. Cryosurgery in the treatment of giant cell tumor: a long-term followup study. Clin Orthop Relat Res. 1999;359:176–188.PubMedCrossRef
28.
Marcove RC, Weis LD, Vaghaiwalla MR, Pearson R. Cryosurgery in the treatment of giant cell tumors of bone: a report of 52 consecutive cases. Clin Orthop Relat Res. 1978;134:275–289.PubMed
29.
Mjoberg B, Pettersson H, Rosenqvist R, Rydholm A. Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand. 1984;55:597–600.PubMedCrossRef
30.
Muramatsu K, Ihara K, Taguchi T. Treatment of giant cell tumor of long bones: clinical outcome and reconstructive strategy for lower and upper limbs. Orthopedics. 2009;32:491.PubMedCrossRef
31.
Nelson DA, Barker ME, Hamlin BH. Thermal effects of acrylic cementation at bone tumour sites. Int J Hyperthermia. 1997;13:287–306.PubMedCrossRef
32.
O’Donnell RJ, Springfield DS, Motwani HK, Ready JE, Gebhardt MC, Mankin HJ. Recurrence of giant-cell tumors of the long bones after curettage and packing with cement. J Bone Joint Surg Am. 1994;76:1827–1833.PubMed
33.
Oh JH, Yoon PW, Lee SH, Cho HS, Kim WS, Kim HS. Surgical treatment of giant cell tumour of long bone with anhydrous alcohol adjuvant. Int Orthop. 2006;30:490–494.PubMedCrossRef
34.
Pals SD, Wilkins RM. Giant cell tumor of bone treated by curettage, cementation, and bone grafting. Orthopedics. 1992;15:703–708.PubMed
35.
Piotrowski JK. Evaluation of exposure to phenol: absorption of phenol vapour in the lungs and through the skin and excretion of phenol in urine. Br J Ind Med. 1971;28:172–178.PubMed
36.
Remedios D, Saifuddin A, Pringle J. Radiological and clinical recurrence of giant-cell tumour of bone after the use of cement. J Bone Joint Surg Br. 1997;79:26–30.PubMedCrossRef
37.
Rock M, Capanna R. The treatment of giant cell tumor of bone. In: Stauffer RN, Ehrlich MG, Fu FH, Kostuik JP, Manske PR, Sim FH, eds. Advances in Operative Orthopaedics. Vol 1. St Louis, MO: Mosby-Year Book; 1993:367–390.
38.
Saiz P, Virkus W, Piasecki P, Templeton A, Shott S, Gitelis S. Results of giant cell tumor of bone treated with intralesional excision. Clin Orthop Relat Res. 2004;424:221–226.PubMedCrossRef
39.
Shih HN, Hsu RW, Sim FH. Excision curettage and allografting of giant cell tumor. World J Surg. 1998;22:432–437.PubMedCrossRef
40.
Shiina S, Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, Hamada E, Takahashi M, Shiratori Y, Terano A. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. AJR Am J Roentgenol. 1993;160:1023–1028.PubMed
41.
Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, Hata Y, Niwa Y, Shiratori Y, Terano A. Percutaneous ethanol injection therapy for hepatocellular carcinoma: a histopathologic study. Cancer. 1991;68:1524–1530.PubMedCrossRef
42.
Szendroi M. Giant-cell tumour of bone. J Bone Joint Surg Br. 2004;86:5–12.PubMed
43.
Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R. Recurrence of curetted and bone-grafted giant-cell tumours with and without adjuvant phenol therapy. Eur J Surg Oncol. 2001;27:200–202.PubMedCrossRef
44.
45.
Turcotte RE, Wunder JS, Isler MH, Bell RS, Schachar N, Masri BA, Moreau G, Davis AM; Canadian Sarcoma Group. Giant cell tumor of long bone: a Canadian Sarcoma Group study. Clin Orthop Relat Res. 2002;397:248–258.
46.
Vult von Steyern F, Bauer HC, Trovik C, Kivioja A, Bergh P, Holmberg Jorgensen P, Folleras G, Rydholm A, Scandinavian Sarcoma Group. Treatment of local recurrences of giant cell tumour in long bones after curettage and cementing: a Scandinavian Sarcoma Group study. J Bone Joint Surg Br. 2006;88:531–535.PubMedCrossRef
47.
Wang P, Zuo C, Qian Z, Tian J, Ren F, Zhou D. Computerized tomography guided percutaneous ethanol injection for the treatment of hyperfunctioning pheochromocytoma. J Urol. 2003;170:1132–1134.PubMedCrossRef
48.
Ward WG Sr, Li G 3rd. Customized treatment algorithm for giant cell tumor of bone: report of a series. Clin Orthop Relat Res. 2002;397:259–270.PubMedCrossRef
49.
Zhen W, Yaotian H, Songjian L, Ge L, Qingliang W. Giant-cell tumour of bone: the long-term results of treatment by curettage and bone graft. J Bone Joint Surg Br. 2004;86:212–216.PubMedCrossRef
Metadata
Title
Similar Local Control between Phenol- and Ethanol-treated Giant Cell Tumors of Bone
Authors
Wei-Hsin Lin, MD
Tsung-Yu Lan, MD
Chih-Yu Chen, MD
Karl Wu, MD
Rong-Sen Yang, MD
Publication date
01-11-2011
Publisher
Springer-Verlag
Published in
Clinical Orthopaedics and Related Research® / Issue 11/2011
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-011-1962-3

Other articles of this Issue 11/2011

Clinical Orthopaedics and Related Research® 11/2011 Go to the issue

Clinical Research

A Minimally Invasive Stabilizing System for Dorsal Pelvic Ring Injuries

Clinical Research

High Dislocation Cumulative Risk in THA versus Hemiarthroplasty for Fractures

Basic Research

Tendinosis-like Histologic and Molecular Changes of the Achilles Tendon to Repetitive Stress: A Pilot Study in Rats

Case Report

Evaluation and Imaging of an Untreated Grade III Hamstring Tear: A Case Report

Symposium: Papers Presented at the 2010 Meeting of the Musculoskeletal Infection Society

Evaluation of Two Sources of Calcium Sulfate for a Local Drug Delivery System: A Pilot Study

Symposium: Bone Repair and Regeneration

The Classic: The Architecture of the Trabecular Bone (Tenth Contribution on the Mechanics of the Human Skeletal Framework)